A specific low dose of oral cannabis (1.25 mg/kg THC equivalent) reversed insulin resistance in obese diabetic rats, but the mechanism differed between peritoneal fat (activated fat "beigeing" genes) and intramuscular fat (increased mitochondrial activity).
Metabolic researchers, endocrinologists, scientists studying cannabis and obesity.
Only the lowest cannabis dose (1.25 mg/kg THC) reversed insulin resistance
What the researchers found
Cannabis at 1.25 mg/kg body weight (relative to THC content) reversed insulin resistance, while higher doses did not. In peritoneal fat, Cidea and UCP1 gene expression (fat beigeing markers) significantly increased. In intramuscular fat, mitochondrial activity increased significantly instead, without beigeing markers.
Why it matters
The dose-dependent reversal of insulin resistance, where only the lowest dose worked, challenges assumptions that more is better. The finding that different fat depots respond through different mechanisms adds complexity to understanding how cannabis affects metabolism.
The numbers in context
Effective dose: 1.25 mg/kg body weight (THC equivalent). Higher doses ineffective. Cidea and UCP1 significantly increased in peritoneal fat. Mitochondrial activity significantly increased in intramuscular fat.
How the study worked
Obese streptozotocin-induced diabetic rat model with oral cannabis administration at multiple doses, comparing effects at peritoneal and intramuscular fat depots.
What this study cannot tell us
Animal model using streptozotocin-induced diabetes, which differs from naturally occurring type 2 diabetes. Only tested oral cannabis, not isolated cannabinoids. Small sample typical of animal studies. Cannot directly extrapolate doses to humans.
How to read the evidence
Animal study using a streptozotocin-induced diabetes model. Results are preliminary and require human validation.
When this study was published
Published in 2023.
The bigger picture
Epidemiological studies have repeatedly found that cannabis users have lower rates of obesity and diabetes despite increased caloric intake. This animal study offers a possible mechanism, though the narrow effective dose range raises questions about translating these findings to humans.
Questions still open
- Why did only the lowest dose reverse insulin resistance?
- Could this dose-response pattern explain contradictory findings in human metabolic studies?
Common questions
Can cannabis treat diabetes?
How did cannabis affect fat in this study?
Read the original research
Effect of oral cannabis administration on the fat depots of obese and streptozotocin-induced diabetic rats.
Phytotherapy research : PTR, 37(5), 1806-1822
Citation
Ramlugon, Sonaal; Levendal, Ruby-Ann; Frost, Carminita L. (2023). Effect of oral cannabis administration on the fat depots of obese and streptozotocin-induced diabetic rats.. Phytotherapy research : PTR, 37(5), 1806-1822. https://doi.org/10.1002/ptr.7694
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk